Refreshing results…
CLPTM1L is a GPI-anchoring pathway component targeted by HCMV
UploadNectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity
Download from doi.orgMissing publications? Search for publications with a matching author name.